[Form 4] Intapp, Inc. Insider Trading Activity
Intapp, Inc. (INTA) insider sale by Michele Murgel. The Chief People & Places Officer reported two dispositions executed on 09/08/2025 under a 10b5-1 trading plan established on June 9, 2025. The filing shows a sale of 18,781 shares at a weighted-average price of $44.7166 (individual trade prices ranged $44.31–$44.99) and a sale of 9,752 shares at a weighted-average price of $45.1328 (individual trade prices ranged $45.00–$45.315). The document lists post-transaction beneficial ownership figures of 203,137 and 193,385 shares on the two reported lines. The report was submitted via attorney-in-fact signature on 09/10/2025.
- None.
- None.
Insights
TL;DR: Routine insider sales under a pre-established 10b5-1 plan; disclosure consistent with Section 16 reporting requirements.
The filing documents two discrete share dispositions by an officer executed under a 10b5-1 plan dated June 9, 2025, which provides an affirmative defense to insider trading allegations when properly implemented. The report includes weighted-average prices and ranges for the underlying executions, and it discloses remaining beneficial ownership on each reported line. From a compliance and market-signaling perspective, these sales appear procedural rather than ad hoc, as they are tied to the written plan. There is no additional information in the filing about the plan terms, timing triggers, or the proportion of total holdings represented by these sales.
TL;DR: Transparent reporting of officer sales; no evidence in this filing of unusual governance concerns.
The Form 4 correctly identifies the reporting person, relationship to the issuer, execution date, and weighted-average prices for multiple transactions within the reported ranges. Use of an attorney-in-fact signature and explicit note that the transactions occurred under a 10b5-1 plan are consistent with governance best practices for orderly insider dispositions. The filing does not provide contextual detail such as percentage of total holdings sold or any changes to option grants or other compensatory actions, limiting deeper governance conclusions.